ReviewBMC pediatrics2026
Mitochondrial dysfunction in hyperkalemic periodic paralysis: A case report and literature review.
Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperkalemic periodic paralysis is a rare autosomal dominant disorder of sodium channels in skeletal muscles caused by pathogenic variants in the SCN4A gene. Emerging evidence suggests an association between this disorder and mitochondrial dysfunction, observed in mice. To our knowledge, there are still no reported cases demonstrating this link in humans. CASE PRESENTATION: We presented a case of hyperkalemic periodic paralysis caused by a heterozygous, de novo, and rare variant, NM_000334.4: c.2078T > C (p.Ile693Thr) in the SCN4A gene, reported for the first time in the Arab region. Our patient experienced intermittent episodes of weakness most frequently in the morning, with sudden onset of limb paralysis and inability to walk. She also exhibited facial myotonia with difficulty opening her mouth and eyelids. She was treated with preventive recommendations to avoid triggers and is now clinically stable. Additionally, the patient presented with mitochondrial dysfunction reported for the first time with hyperkalemic periodic paralysis.
conclusionThis study is the first clinical report of mitochondrial respiratory chain enzymes dysfunction in a patient with hyperkalemic periodic paralysis caused by a rare variant, c.2078T > C (p.Ile693Thr), in the SCN4A gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.